Columbia University Vagelos College of Physicians and Surgeons

Cue Health Appoints David Tsay, MD, PhD, as Chief Medical Officer

Retrieved on: 
Thursday, September 8, 2022
Cue, Columbia University Irving Medical Center, COVID-19, CEO, Computer science, Columbia University Vagelos College of Physicians and Surgeons, Artificial intelligence, Washington Apple Health, Physician, Hand, Doctor of Philosophy, Columbia University College of Dental Medicine, Central Drugs Standard Control Organisation, Associate, Physics, Internal medicine, Union, Interim order, Health Canada, NYP, Multimedia, Data science, New, MD, Nasdaq, FDA, Communication, CE, Automation, PSAR, Health Sciences Authority, Surgeon, Cardiology, Health, Patient, Medical device, Management, Medicine, Research, Apple

SAN DIEGO, Sept. 8, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed David Tsay, MD, PhD, as its Chief Medical Officer. Dr. Tsay comes to Cue with more than 20 years of experience in clinical medicine, research, and health technology. Most recently, Dr. Tsay served at Apple, where he led an Apple Health clinical team in developing new Health products, including FDA-cleared products in cardiovascular health.

Key Points: 
  • Dr. Tsay Brings Two Decades of Expertise in Clinical Medicine, Research, and Health Technology to Cue
    SAN DIEGO, Sept. 8, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced that it has appointed David Tsay, MD, PhD, as its Chief Medical Officer.
  • Dr. Tsay comes to Cue with more than 20 years of experience in clinical medicine, research, and health technology.
  • Most recently, Dr. Tsay served at Apple, where he led an Apple Health clinical team in developing new Health products, including FDA-cleared products in cardiovascular health.
  • As Chief Medical Officer, Dr. Tsay will help define future Cue diagnostic products and services.

Bassett Receives $82 Million Scriven Foundation Grant to Support Improved Access to Care and Key Investments in Staff

Retrieved on: 
Thursday, August 25, 2022
Partnership, Patient, Columbia University, COVID-19, Columbia University Vagelos College of Physicians and Surgeons, CEO, Research, Columbia University Irving Medical Center, Physician, Outline of health sciences, Rural health, Dean, Investment, MHA, Hospital, Organization, Education, MD, GLOBE, Scriven, Facebook, Nursing, Surgeon, Health, Environment, Pharmaceutical industry, Medicine, Director

Cooperstown, NY, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bassett Medical Center is the recipient of an $82 million grant from the Scriven Foundation to make rapid improvements resulting in greater patient care access.

Key Points: 
  • Cooperstown, NY, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bassett Medical Center is the recipient of an $82 million grant from the Scriven Foundation to make rapid improvements resulting in greater patient care access.
  • The organizations tremendous footprint connects many thousands of patients with care who otherwise would not have access.
  • We are deeply grateful to the Scriven Foundation and Jane Forbes Clark for their remarkable support of Bassett and the communities we serve.
  • Our continued success as an independent health system is possible because of mission-driven partnerships with organizations like the Scriven Foundation.

Chapters Health System Names Dr. Tara Friedman as New Chief Medical Officer

Retrieved on: 
Monday, August 15, 2022
Hospital, Association of Jewish Aging Services, Hospice and palliative medicine, Colgate University, Internal medicine, S-1 Executive Committee, Capitol Hill, American Academy, Palliative care, Facebook, Leadership, Hospital of the University of Pennsylvania, Director, AAHPM, Aspire, Times Publishing Company, Physician, Workplace, Health, Surgeon, Executive Committee, Tampa Bay Times, Family, Twitter, Education, Columbia University Vagelos College of Physicians and Surgeons, Ageing, Mount Sinai Medical Center, American Academy of Hospice and Palliative Medicine, Board of directors, MBA, University, LinkedIn, Food and Drug Administration, Medical degree, Columbia University College of Dental Medicine, Management, Medicine, Psychology, Anthem, Hospice

TAMPA, Fla., Aug. 15, 2022 /PRNewswire-PRWeb/ -- Chapters Health System, one of the nation's premier not-for-profit, community-based healthcare organizations headquartered in Temple Terrace, names Tara Friedman, M.D., FAAHPM, as the organization's new chief medical officer. She will start in this role on Monday, September 19, 2022. Dr. Friedman will provide leadership and oversight of all medical services functions across the entire enterprise.

Key Points: 
  • Chapters Health System, one of the nation's premier not-for-profit, community-based healthcare organizations headquartered in Temple Terrace, names Tara Friedman, M.D., FAAHPM, as the organization's new chief medical officer.
  • TAMPA, Fla., Aug. 15, 2022 /PRNewswire-PRWeb/ -- Chapters Health System, one of the nation's premier not-for-profit, community-based healthcare organizations headquartered in Temple Terrace, names Tara Friedman, M.D., FAAHPM, as the organization's new chief medical officer.
  • "At Chapters Health, we are pleased to have Dr. Friedman join our family," said Andrew Molosky, MBA, FACHE, CHPCA, president and chief executive officer for Chapters Health.
  • Prior to joining Chapters Health, Dr. Friedman was the vice president and national medical officer for Aspire Health, a subsidiary of Anthem.

Integrated Health Partners of Southern California (IHP) Announces Appointment of Raj Dugel, MD, to Medical Director

Retrieved on: 
Wednesday, August 10, 2022
Multimedia, Medicine, Parenthood, IHP, CEO, Arvinder Singh Soin, Senior, Providence Health & Services, Population, Federally Qualified Health Center, Policy, Human, Physician, Department, Patient, Surgeon, Instagram, Optometry, Family, Twitter, SAN, Columbia University Vagelos College of Physicians and Surgeons, View, Partnership, Safety, Region, Pacific Southwest, HCP, Health, Medical director, USC, Columbia University College of Dental Medicine, Georgetown University, Facebook, Ophthalmology, Orange, MD

SAN DIEGO, Aug. 10, 2022 /PRNewswire/ -- Health Center Partners (HCP) of Southern California, the region's preeminent authority and health care policy advocate for community health and underserved patient populations, today announced the appointment of Raj Dugel, MD, to Medical Director of its subsidiary, Integrated Health Partners of Southern California (IHP), a clinically integrated network consisting of nine member health centers, with 300,000 lives under management, in San Diego and Riverside Counties. As a powerful advocate for primary care service providers and their patients, IHP seeks to improve health outcomes by improving quality of care through coordinating and integrating the efforts of member health centers. Dr. Dugel will provide clinical and population health leadership in partnership with IHP's member health centers throughout San Diego and Riverside Counties. As part of this important role, he will leverage his expertise in clinical medicine, medical informatics, and network development to help strengthen health centers' clinical operations and ultimately improve care quality and health outcomes.

Key Points: 
  • SAN DIEGO, Aug. 10, 2022 /PRNewswire/ -- Health Center Partners (HCP) of Southern California, the region's preeminent authority and health care policy advocate for community health and underserved patient populations, today announced the appointment of Raj Dugel, MD, to Medical Director of its subsidiary, Integrated Health Partners of Southern California (IHP), a clinically integrated network consisting of nine member health centers, with 300,000 lives under management, in San Diego and Riverside Counties.
  • Dr. Dugel will provide clinical and population health leadership in partnership with IHP's member health centers throughout San Diego and Riverside Counties.
  • "Health Center Partners is proud and pleased to welcome Raj to our family of companies," said Henry Tuttle, president and CEO of Health Center Partners of Southern California.
  • A premier consortium of primary health care organizations, Health Center Partners (HCP) is the voice and advocate for its members who serve the health needs of communities throughout southern California.

ReCor Medical and Otsuka Medical Devices Announce Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise™ System for the Treatment of Hypertension

Retrieved on: 
Tuesday, July 26, 2022
Medical Devices, Health, Radiology, Clinical Trials, Cardiology, CA, Physician, CEO, Columbia University Vagelos College of Physicians and Surgeons, Ōtsuka, US, COVID-19, ReCore, US FDA, PMA, Hospital, Principal investigator, Clinical trial, CE, FDA, TRIO, SOLO, Tokyo Stock Exchange, Patient, Hypertension, Surgeon, Columbia University, Pharmaceutical industry, EU, Medicine

The RADIANCE II US FDA IDE pivotal trial is a randomized, sham-controlled clinical trial of the ReCor Paradise uRDN System for the treatment of patients with uncontrolled hypertension.

Key Points: 
  • The RADIANCE II US FDA IDE pivotal trial is a randomized, sham-controlled clinical trial of the ReCor Paradise uRDN System for the treatment of patients with uncontrolled hypertension.
  • We at Otsuka are very pleased with the positive outcome of the RADIANCE II study, said Kazumichi Kobayashi, Executive Deputy President of Otsuka Medical Devices.
  • With RADIANCE II, ReCor now has a third positive trial, with more than 500 patients randomized in the RADIANCE Global Program.
  • ReCor has also begun the Global Paradise System (GPS) Registrya real-world study of up to 3,000 patients with uncontrolled hypertension.

SIMOS SIMEONIDIS, PHD JOINS ALLY BRIDGE GROUP AS CO-CEO AND CO-CIO

Retrieved on: 
Thursday, July 21, 2022
Gene expression, Novartis, Loyola University Chicago, Investment, Health care, University, Company, Specialization, Morgan Stanley, Wharton School of the University of Pennsylvania, Industry, Cone Health Women's Hospital, Doctor of Philosophy, Physician, Royal Bank, Beth Israel Deaconess Medical Center, Associate, Columbia University Vagelos College of Physicians and Surgeons, Sarissa, BS, Hospital, Wendell Pritchett, Wall Street, Loyola University, Royal Bank of Canada, MBA, Business development, Senior, Harvard Medical School, Master of Philosophy, Letter, Surgeon, Columbia University, Health, Financial services, Security (finance), Management, Medicine, Brigham, Biology, Research, Cellular

NEW YORK, July 21, 2022 /PRNewswire/ --Ally Bridge Group (the "Firm") is pleased to announce Simos Simeonidis, PhD joined the Firm as Co-Chief Executive Officer and Co-Chief Investment Officer based in New York.

Key Points: 
  • NEW YORK, July 21, 2022 /PRNewswire/ --Ally Bridge Group (the "Firm") is pleased to announce Simos Simeonidis, PhD joined the Firm as Co-Chief Executive Officer and Co-Chief Investment Officer based in New York.
  • Dr. Simeonidis is also assuming the role of Portfolio Manager for Ally Bridge Group's public equity strategy.
  • Ally Bridge Group is a global healthcare investment manager focused on high-impact life science innovation addressing unmet medical needs.
  • Ally Bridge Group was founded in 2013 by Frank Yu and has offices in New York and Hong Kong.

SIMOS SIMEONIDIS, PHD JOINS ALLY BRIDGE GROUP AS CO-CEO AND CO-CIO

Retrieved on: 
Thursday, July 21, 2022
Gene expression, Novartis, Loyola University Chicago, Investment, Health care, University, Company, Specialization, Morgan Stanley, Wharton School of the University of Pennsylvania, Industry, Cone Health Women's Hospital, Doctor of Philosophy, Physician, Royal Bank, Beth Israel Deaconess Medical Center, Associate, Columbia University Vagelos College of Physicians and Surgeons, Sarissa, BS, Hospital, Wendell Pritchett, Wall Street, Loyola University, Royal Bank of Canada, MBA, Business development, Senior, Harvard Medical School, Master of Philosophy, Letter, Surgeon, Columbia University, Health, Financial services, Security (finance), Management, Medicine, Brigham, Biology, Research, Cellular

NEW YORK, July 21, 2022 /PRNewswire/ --Ally Bridge Group (the "Firm") is pleased to announce Simos Simeonidis, PhD joined the Firm as Co-Chief Executive Officer and Co-Chief Investment Officer based in New York.

Key Points: 
  • NEW YORK, July 21, 2022 /PRNewswire/ --Ally Bridge Group (the "Firm") is pleased to announce Simos Simeonidis, PhD joined the Firm as Co-Chief Executive Officer and Co-Chief Investment Officer based in New York.
  • Dr. Simeonidis is also assuming the role of Portfolio Manager for Ally Bridge Group's public equity strategy.
  • Ally Bridge Group is a global healthcare investment manager focused on high-impact life science innovation addressing unmet medical needs.
  • Ally Bridge Group was founded in 2013 by Frank Yu and has offices in New York and Hong Kong.

Carolyn Everson Elected to Board of Directors of The Coca-Cola Company

Retrieved on: 
Tuesday, July 19, 2022
Packaging, Retail, Convenience Store, Manufacturing, Supermarket, Food, Beverage, Leadership, Council, Global, The Coca-Cola Company, Creative Artists Agency, CEO, Harvard Business School, Villanova University, Microsoft, LinkedIn, Everson, Sport, Carbon, NYSE, Twitter, Coca-Cola, Gold Peak, Foreign relations, Dasani, Meta, AdeS, Brothers in Unity, Multimedia, Ayataka, Walt Disney Imagineering, Sprite, Instagram, Coffee, Humane society, Columbia University Vagelos College of Physicians and Surgeons, SmartWater, Management, Bottled water, Facebook, Powerade, Instacart, Viacom, Primedia

The Coca-Cola Company today announced that Carolyn Everson, a business leader with extensive experience in media and consumer-facing companies, has been elected as a director.

Key Points: 
  • The Coca-Cola Company today announced that Carolyn Everson, a business leader with extensive experience in media and consumer-facing companies, has been elected as a director.
  • Prior to Facebook, Everson was corporate vice president of the Global Advertising Sales and Trade Marketing Teams at Microsoft.
  • Carolyn has deep experience across several major companies, including leadership on a global level, said James Quincey, Chairman and CEO of The Coca-Cola Company.
  • The Coca-Cola Company (NYSE: KO) is a total beverage company with products sold in more than 200 countries and territories.

Atonarp Welcomes Nobel Laureate James E. Rothman to its Board of Directors

Retrieved on: 
Tuesday, July 19, 2022
Research, Nobel Prize, Johnson & Johnson, Golgi, CEO, Yale University, Yale School of Medicine, Golgi apparatus, Communication, Department, Nanotechnology, Merck & Co., Columbia University Vagelos College of Physicians and Surgeons, Memorial, Brain, Faculty, Memorial Sloan Kettering Cancer Center, Cell biology, Nobel Prize in Physiology or Medicine, Multimedia, Biophysics, Genentech, Company, Eli Lilly, Efficiency, Insulin, Blood, Sterling Professor, ATON, Lipid, Exocytosis, GlaxoSmithKline, Stanford University, Virus, Medical device, Science, Physiology, Princeton University, Medicine

Dr. Rothman will add his expertise to inform and advance the Company's roadmap of next-generation molecular sensing and diagnostic products.

Key Points: 
  • Dr. Rothman will add his expertise to inform and advance the Company's roadmap of next-generation molecular sensing and diagnostic products.
  • Dr. Rothman is currently the Sterling Professor and Chair of the Department of Cell Biology at Yale University School of Medicine.
  • Prior to joining the faculty at Yale in 2008, he served as Chief Scientist of General Electric Healthcare and its predecessor, Amersham.
  • Dr. Rothman also served as an advisor to top research management at Genentech, Merck & Co., Johnson & Johnson, GlaxoSmithKline, and Eli Lilly.

Karl J. Schroeder, MD is being recognized by Continental Who's Who

Retrieved on: 
Thursday, July 14, 2022
New York State Psychiatric Institute, Physician, Gerald Loeb Lifetime Achievement Award winners, Mental disorder, Education, Family, Notre Dame, Child, Continental, Columbia University Vagelos College of Physicians and Surgeons, Cognition, History of the United States, American Board of Psychiatry and Neurology, Patient, Ministry of Health (New South Wales), Medical degree, MD, Private practice, Injury, Depression, Diagnosis, Psychotherapy, United States Army, Army of the United States, Health, House, Disorder, American Board of Commissioners for Foreign Missions, Columbia University, Gardening, Stroke, ABPN, Pharmaceutical industry, Medical device, Medicine, Psychiatry, Neurology, Surgeon, Paleontology

SUFFERN, N.Y., July 14, 2022 /PRNewswire/ -- Karl J. Schroeder, MD is being recognized by Continental Who's Who as a Lifetime Achiever for his distinguished career in the Psychiatry field and in acknowledgment of his work in private practice.

Key Points: 
  • SUFFERN, N.Y., July 14, 2022 /PRNewswire/ -- Karl J. Schroeder, MD is being recognized by Continental Who's Who as a Lifetime Achiever for his distinguished career in the Psychiatry field and in acknowledgment of his work in private practice.
  • He has provided excellent patient care in private practice at 104 Montebello Road in Suffern, NY, for over 46 years.
  • Before working in private practice, Dr. Schroeder obtained his college education at Notre Dame, where he received his undergraduate degree.
  • Dr. Schroeder has been recognized for his decades of work by IssueWire and Health News Today, who released his profiles in 2021.